We are live on ! Find out more
SBFMW

Sunshine Biopharma Inc Warrant
SBFMW

3 hedge funds and large institutions have $12.2K invested in Sunshine Biopharma Inc Warrant in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more capital invested

Capital invested by funds: $6.87K → $12.2K (+$5.31K)

50% more funds holding

Funds holding: 23 (+1)

0.88% more ownership

Funds ownership: 2.14%3.02% (+0.88%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$6.37K
2
CS
Clear Street
New York
+$21

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.44K
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$6.16K -$2.44K -10,886 -26%
UBS Group
2
UBS Group
Switzerland
$6.01K +$6.37K +28,442 +2,207%
CS
3
Clear Street
New York
$19 +$21 +94 New

SBFMW Hedge Fund Activity: Q1 2025 in Review

3 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q1 2025, worth a combined $12.2K — up 77% from $6.87K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new SBFMW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $6.37K. The largest seller was Citadel Advisors, cutting an estimated $2.44K.

  • 3 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q1 2025, up from 2 in Q4 2024.
  • Funds reported $12.2K of Sunshine Biopharma Inc Warrant stock for Q1 2025, up 77% quarter-over-quarter.
  • 1 fund opened new Sunshine Biopharma Inc Warrant positions in Q1 2025 and 0 closed out, a net change of +1 holder.
  • The largest Sunshine Biopharma Inc Warrant buyer in Q1 2025 was UBS Group, an estimated $6.37K added.
  • The largest Sunshine Biopharma Inc Warrant seller in Q1 2025 was Citadel Advisors, an estimated $2.44K sold.

Based on aggregated 13F filings for Q1 2025.